US Corporate Board Director Changes SEC Filings — June 23, 2026

23-06-2026

Hawkeye Systems, Inc. (HWKE) filed an 8-K on June 23, 2026, reporting multiple corporate actions approved on June 17, 2026. The company dismissed its independent auditor Fruci & Associates II, PLLC and appointed Grassi & Co., CPAs, P.C. as its new auditor, with no disagreements or reportable events in prior audits. Stockholders approved a name change to Hawkeye Digital, Inc., a massive increase in authorized shares from 450 million to 10.05 billion (including a 10 billion common stock authorization), a reverse stock split (1-for-2 to 1-for-20), and the adoption of the 2026 Equity Incentive Plan. The majority stockholder, Hawkeye Holdco, LLC, holding ~90.1% of voting power, consented to all proposals. No financial results or period-over-period comparisons were provided in this filing.

• · The reverse stock split ratio is not less than 1-for-2 nor greater than 1-for-20, with implementation at the Board's discretion before June 17, 2027.
• · The Amended and Restated Articles of Incorporation will become effective 21 days after the Information Statement is mailed to stockholders.
• · The 2026 Equity Incentive Plan allows for Incentive Stock Options, Non-qualified Stock Options, Stock Appreciation Rights, Restricted Awards, Performance Share Awards, Cash Awards, and Other Equity-Based Awards.
• · No disagreements or reportable events occurred with the former auditor during the audits for fiscal years ended June 30, 2024 and 2025, or through June 17, 2026.
• · The company is not an emerging growth company.

23-06-2026

Comscore, Inc. held its annual meeting on June 16, 2026, where stockholders approved an amendment to the 2018 Equity and Incentive Compensation Plan to increase available shares by 3,000,000, and elected two Class I directors (David Kline and Brian Wendling). The compensation of named executive officers was approved on a non-binding advisory basis, and Deloitte & Touche LLP was ratified as the independent auditor for fiscal year 2026. The amendment to the Plan received 19,593,512 votes in favor, 4,117,350 against, and 119,352 abstentions, with 1,240,084 broker non-votes.

• · The amendment to the Plan was approved with 19,593,512 votes in favor, 4,117,350 against, and 119,352 abstentions, plus 1,240,084 broker non-votes.
• · Executive compensation (say-on-pay) received 23,119,135 votes in favor, 659,092 against, and 51,987 abstentions.
• · Ratification of Deloitte & Touche LLP as auditor was approved with 25,048,171 votes in favor, 18,634 against, and 3,493 abstentions.
• · Series C Preferred Stock shares (8,795,201) were required to vote neutrally on all proposals.

23-06-2026

CVR Energy (CVI) and CVR Partners (UAN) announced the promotion of Dane Neumann from Executive Vice President and CFO to President and CEO of both entities and their Boards of Directors, effective June 18, 2026, following Mark Pytosh's resignation for personal reasons. The leadership change is framed as a catalyst for growth and value creation, though no specific financial or operational targets were disclosed, leaving near-term performance expectations uncertain.

• · Resignation of former CEO Mark Pytosh was for personal reasons and effective June 18, 2026.
• · New CEO Dane Neumann previously served as EVP and CFO of the CVR entities.
• · CVR Energy holds approximately 37% of CVR Partners common units.
• · CVR Partners' facilities include Coffeyville, KS (1,300 TPD ammonia, 3,100 TPD UAN, 89 MMSCFD hydrogen) and East Dubuque, IL (1,075 TPD ammonia, 950 TPD UAN).

23-06-2026

CVR Energy (CVI) and CVR Partners (UAN) announced the promotion of Dane Neumann from EVP & CFO to President and CEO of both entities, effective June 18, 2026, following Mark Pytosh's resignation for personal reasons. The filing contains no quantitative financial data; the leadership change is the sole material event with forward-looking statements about growth and shareholder returns but no specific metrics or performance comparisons.

• · CVR Energy subsidiaries serve as the general partner and own approximately 37% of the common units of CVR Partners.
• · CVR Partners operates a nitrogen fertilizer manufacturing facility in Coffeyville, Kansas (1,300 ton-per-day ammonia unit, 3,100 ton-per-day UAN unit, dual-train gasifier complex with 89 million standard cubic feet per day hydrogen capacity) and a facility in East Dubuque, Illinois (1,075 ton-per-day ammonia unit, 950 ton-per-day UAN unit).
• · The effective date of the appointment is June 18, 2026, and the announcement was made on June 22, 2026.

23-06-2026

Avalo Therapeutics appointed Ron Philip to its Board of Directors effective June 23, 2026. Mr. Philip will serve on the Compensation Committee and Science, Development and Commercial Advisory Committee, and will receive a non-qualified stock option award for 40,200 shares vesting over three years. He brings extensive biotech leadership experience from roles at Orbital Therapeutics, Spark Therapeutics, and Pfizer.

• · Mr. Philip's appointment is effective immediately and he will serve until the 2027 Annual Meeting.
• · He will serve on the Compensation Committee and Science, Development and Commercial Advisory Committee.
• · The stock option vests in three equal annual installments starting June 23, 2027.
• · Mr. Philip served as CEO of Orbital Therapeutics until its acquisition by Bristol-Myers Squibb in December 2025.
• · He previously served as CEO of Spark Therapeutics from May 2017 to August 2024.
• · Mr. Philip holds a B.S. in Computer Information Systems from Drexel University.

23-06-2026

Athene Holding Ltd. appointed Robert Brackenbury, former Deputy CIO of the State of Michigan Retirement System, as an independent director effective June 23, 2026. Brackenbury brings decades of experience overseeing over $170 billion in pension and state trust fund assets, which is expected to strengthen the board's expertise in retirement solutions and investment management.

• · Brackenbury previously served as a Michigan State Tax Tribunal judge and Assistant Attorney General.
• · He also served as a U.S. Army officer on active duty and in the U.S. Army Reserve.
• · He currently serves on investment committees for community foundations in Michigan.
• · Brackenbury holds a B.S. in mathematics and economics, an M.A. in economics from Eastern Michigan University, an MBA from the University of Michigan Ross School of Business, and a J.D. from Wayne State University Law School.
• · He completed the Senior Executives in State and Local Government Program at Harvard Kennedy School.
• · Athene has operations in the United States, Bermuda, Canada, and Japan.

23-06-2026

Dragonfly Energy Holdings Corp. appointed Lukas Lutz as an independent director and member of the Nominating and Corporate Governance Committee, effective June 18, 2026, replacing Brian Nelson. Mr. Lutz received 10,000 restricted stock units (RSUs) with half vesting immediately and half vesting on the one-year anniversary. No other material financial or operational changes were disclosed.

• · Mr. Lutz was appointed as a Class B director with a term expiring at the 2027 annual meeting.
• · The RSU grant is subject to the Company's 2022 Equity Incentive Plan.
• · Mr. Lutz will be compensated per the Company's standard non-employee director fee practice as described in the 2025 Form 10-K.
• · There are no arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.

23-06-2026

UMH Properties, Inc. appointed Kevin Miller as Executive Vice President, Chief Financial Officer, and Treasurer effective June 1, 2026, and entered into an employment agreement with him on June 18, 2026. The agreement provides an annual base salary of $430,000, a target annual cash bonus of 60% of base salary, and eligibility for long-term equity awards under the 2023 Equity Incentive Award Plan. The initial term ends January 1, 2027, with automatic one-year renewals.

• · The Miller Agreement includes performance-based vesting for equity awards based on metrics such as normalized FFO per share growth, total shareholder return, same property occupancy increase, NOI growth, sale increase, acquisitions, development of sites, capital raising, and ESG
• · If terminated without cause (or for good reason/non-renewal), Miller receives three times the sum of base salary plus average annual bonus over the prior three years, paid in 36 monthly installments
• · In the event of termination due to death or disability, the multiplier is one time, paid in 12 monthly installments
• · Upon a change of control termination within 24 months, the Miller Termination Benefit is paid as a single lump sum within 60 days
• · Equity awards may be based in part on the Company's total shareholder return relative to the MSCI US REIT Index

23-06-2026

Anika Therapeutics held its 2026 Annual Meeting on June 18, 2026, where stockholders elected three Class III directors (Gary P. Fischetti, John B. Henneman III, and Stephen D. Griffin), ratified Deloitte & Touche as independent auditor, and approved executive compensation on a non-binding advisory basis. Stockholders also approved a sixth amendment and restatement of the 2017 Omnibus Incentive Plan, increasing authorized shares from 5,760,000 to 6,110,000, and an amendment to the 2021 Employee Stock Purchase Plan, doubling reserved shares from 200,000 to 400,000. Notably, while director elections and auditor ratification passed with strong support, the advisory vote on executive compensation and the incentive plan amendment received significant opposition (11.7% and 12.0% of votes cast against, respectively).

• · The Annual Meeting was held on June 18, 2026, with 84.14% voter turnout.
• · Proposal 1: All three director nominees were elected with strong support (Fischetti: 9,248,053 For; Henneman: 8,829,035 For; Griffin: 9,309,707 For).
• · Proposal 2: Ratification of Deloitte & Touche as auditor passed overwhelmingly (11,136,590 For, 24,966 Against).
• · Proposal 3: Advisory vote on executive compensation passed with 8,268,676 For, 1,093,946 Against, and 31,179 Abstain (excluding 1,801,866 broker non-votes).
• · Proposal 4: Incentive plan amendment passed with 8,013,994 For, 1,347,970 Against, and 31,837 Abstain (excluding 1,801,866 broker non-votes).
• · Proposal 5: ESPP amendment passed with 9,110,892 For, 257,394 Against, and 25,515 Abstain (excluding 1,801,866 broker non-votes).
• · The Revised Seventh Amended Plan increases authorized shares from 5,760,000 to 6,110,000 (a 350,000 share increase).
• · The ESPP amendment doubles reserved shares from 200,000 to 400,000.
• · No other provisions of the 2017 Plan or ESPP were amended.

23-06-2026

Worthington Enterprises reported fiscal Q4 2026 net sales of $371.5M, up 17% YoY, driven by $44.1M from acquisitions and 3% organic growth. Net earnings surged to $48.1M from $3.6M in the prior year quarter, while adjusted EPS declined to $0.97 from $1.06. For the full year, net sales rose 20% to $1.4B, adjusted EBITDA grew 12% to $295.8M, and the company completed acquisitions of Elgen Manufacturing and LSI Group. However, adjusted EBITDA in the Building Products segment decreased $2.7M due to lower equity income from ClarkDietrich and unfavorable product mix.

• · Q4 FY2026 operating income was $23.2M, up from a loss of $30.4M in Q4 FY2025, which included $52.2M in nonrecurring items primarily from a non-cash intangible asset write-down in the GTI business.
• · Equity in net income of unconsolidated affiliates decreased $4.6M to $38.1M, driven by a $6.8M decline from ClarkDietrich, partially offset by higher contributions from Workhorse and SES joint ventures.
• · Income tax expense increased to $11.7M from $4.7M, with an annual effective rate of 22.9% vs 26.1% in the prior year.
• · Total debt at quarter end was $305.9M, up $3.0M from May 31, 2025, due to remeasurement of euro-denominated notes; no borrowings under the $500M revolving credit facility.
• · Cash decreased $222.4M to $27.7M, primarily reflecting the acquisitions of Elgen and LSI.
• · Capital expenditures in Q4 included $6.6M for facility modernization projects expected to be completed in fiscal 2027.
• · Building Products adjusted EBITDA decreased $2.7M despite higher sales, due to lower ClarkDietrich equity income and unfavorable product mix.
• · Consumer Products net sales were essentially flat (+$0.6M), with higher average selling prices mostly offset by lower volume.
• · The company declared a quarterly dividend of $0.20 per share, a 5% increase from the prior quarter, payable September 29, 2026.
• · Full-year adjusted EBITDA grew 12% to $295.8M, and adjusted net earnings increased 8% to $167.6M.

23-06-2026

Team, Inc. announced the departure of CFO Nelson Haight effective June 22, 2026, and the appointment of Clinton Roeder as his successor. Haight will receive severance benefits including $603,750 in salary continuation, a prorated 2026 bonus, and accelerated equity vesting. Roeder brings over 30 years of financial experience and will receive a $500,000 base salary, a target bonus of 75% of base salary, and $500,000 in equity grants. The transition appears orderly with no disagreements cited, but the departure of a key executive introduces leadership transition risk.

• · Nelson Haight will serve as Special Advisor to the CEO from June 22 to July 3, 2026, receiving his normal base salary through that date.
• · Haight's outstanding unvested time-based RSUs will immediately vest; performance share units will continue to vest with payout prorated by 92%.
• · Clinton Roeder most recently served as EVP and CFO of PrimeFlight Aviation Services from May 2020 to May 2026.
• · Roeder's equity grant is split 30% RSUs (3-year vesting) and 70% PSUs (cliff vest Dec 31, 2028 based on 3-year Adjusted EBITDA).
• · No family relationships or material interests in transactions were reported for Roeder.

23-06-2026

QuidelOrtho Corp appointed Micah Young as CFO effective July 6, 2026, succeeding Joseph M. Busky who is retiring. Young brings over two decades of leadership experience from Masimo Corp and other medical technology firms. The change is a standard leadership transition with no financial performance data disclosed.

• · Micah Young previously served as Executive Vice President and CFO of Masimo Corporation (2017-2026).
• · Joseph Busky previously announced his retirement and will stay in an advisory role.
• · Mr. Young holds a Bachelor of Science in Accounting and Criminal Justice from Indiana Wesleyan University and is a CPA (inactive).

23-06-2026

Sky Harbour Group Corporation held its 2026 Annual Meeting on June 18, 2026, where stockholders approved an amendment to the 2022 Incentive Award Plan, increasing the share reserve by 1,500,000 shares of Class A common stock. All seven director nominees were elected, and EisnerAmper LLP was ratified as the independent auditor for fiscal 2026. The say-on-pay proposal passed with strong support (over 49.6 million votes for), and stockholders selected a three-year frequency for future advisory votes on executive compensation.

• · The Amendment did not modify any other terms of the 2022 Incentive Award Plan.
• · Proposal 3 (Ratification of EisnerAmper LLP) received 57,642,943 votes for, 13,514 against, and 899 abstentions.
• · Proposal 4 (Say-on-Pay) received 49,634,762 votes for, 134,564 against, and 4,088 abstentions, with 7,883,942 broker non-votes.
• · Proposal 5 (Frequency of Future Advisory Votes) resulted in 46,178,244 votes for 3 years, 3,548,221 for 1 year, 7,189 for 2 years, and 39,760 abstentions.
• · The Board determined that future stockholder advisory votes on executive compensation will be held every three years.

23-06-2026

PRA Group held its 2026 Annual Meeting on June 16, 2026, where stockholders approved an amendment to the 2022 Omnibus Incentive Plan to increase the share limit by 3,500,000 shares. All nine director nominees were elected, and the appointment of Ernst & Young LLP as independent auditor for 2026 was ratified. However, the advisory vote on named executive officer compensation (Say-on-Pay) and the equity plan amendment each received notable opposition, with 6.9% and 17.0% of votes cast against, respectively.

• · Director Lance L. Weaver received the highest number of against votes among nominees (3,106,214 against), representing 9.7% of votes cast excluding broker non-votes.
• · Director Geir L. Olsen received 2,511,714 against votes (7.8% of votes cast excluding broker non-votes).
• · The ratification of Ernst & Young LLP as independent auditor passed with 99.6% of votes cast in favor (33,877,552 for, 146,010 against).
• · The equity plan amendment required a majority of votes cast and passed with 83.0% in favor (26,552,984 for, 5,442,103 against).
• · Broker non-votes totaled 2,029,734 on all director elections and the Say-on-Pay and equity plan proposals.

23-06-2026

F5, Inc. appointed Gavin Munroe to its board of directors effective June 17, 2026. Munroe, former CIO and Transformation Head at Commonwealth Bank of Australia, brings over 25 years of technology leadership in financial services and will serve on the Audit and Risk committees. The board expands to 10 members, 9 of whom are independent.

• · Munroe will serve on the Audit and Risk committees.
• · He most recently served as CIO and Transformation Head at Commonwealth Bank of Australia.
• · He has held technology leadership roles at HSBC, Bank of America/Merrill Lynch, Synechron, and Saxon (Morgan Stanley).
• · Munroe earned a Bachelor of Science in Computer Science from The University of Port Elizabeth.
• · F5 is the global leader in delivering and securing every app and API.

23-06-2026

Alto Ingredients held its 2026 Annual Meeting on June 23, 2026, where stockholders approved all four proposals: the election of five directors, the advisory say-on-pay resolution, the 2026 Omnibus Incentive Plan (authorizing up to 7,000,000 shares), and the ratification of RSM US LLP as independent auditor. The new equity plan replaces the prior plan and will remain in effect until 2036.

• · Director election results: Bryon T. McGregor received the most votes for (29,943,055); Dianne S. Nury received the most votes withheld (1,089,609).
• · Each director election had approximately 20.9 million broker non-votes.
• · Say-on-pay approval: 25,740,806 for vs. 1,044,080 against (93.4% of shares voted for).
• · 2026 Omnibus Incentive Plan approval: 25,660,172 for vs. 1,406,965 against (94.8% of shares voted for).
• · Ratification of RSM US LLP: 47,300,626 for vs. 1,027,058 against (97.9% of shares voted for); no broker non-votes on this proposal because it is a routine matter.
• · The 2026 Plan replaces the predecessor plan (not named) and no further awards will be made under the prior plan.
• · The 2026 Plan will remain in effect until June 23, 2036, unless terminated earlier.

23-06-2026

Burke & Herbert Financial Services Corp. appointed Roy E. Halyama, current EVP and CFO, as President of the Company and Burke & Herbert Bank & Trust, effective July 1, 2026, following the retirement of H. Charles Maddy, III on June 30, 2026. No modifications to Mr. Halyama's compensation were made in connection with the appointment.

• · Mr. Halyama, age 58, has served as EVP and CFO since joining the company in 2021.
• · Prior to BHRB, he was CFO of a PNC affiliate from 2019 to 2021.
• · He holds a BS in Business Administration/Accounting and an MBA in Finance from The Ohio State University.
• · No family relationships exist between Mr. Halyama and any director or executive officer.
• · No arrangements or understandings exist regarding his appointment, and no transactions under Item 404(a) are reportable.

23-06-2026

At its 2026 Annual Meeting on June 22, 2026, Schrödinger, Inc. stockholders approved an amendment to the 2022 Equity Incentive Plan, increasing authorized shares by 3,000,000, and ratified KPMG LLP as independent auditor for FY 2026. All four proposals passed, including the advisory vote on executive compensation with strong support (51.3M shares FOR vs 0.9M AGAINST). However, the equity plan amendment faced notable opposition, with 10.8M shares (20.7% of votes cast) voting against it, and director Rosana Kapeller-Libermann received the lowest support among the three Class III director nominees, with 10.7M shares (24.9% of votes cast) voting against her election.

• · The 2026 Annual Meeting was held on June 22, 2026.
• · Stockholders approved the 2026 Plan Amendment, increasing the share reserve by 3,000,000 shares.
• · KPMG LLP was ratified as the independent registered public accounting firm for FY 2026 with 61,674,114 shares FOR and only 179,559 AGAINST.
• · The advisory vote on executive compensation passed with 51,345,375 shares FOR and 870,926 AGAINST.
• · Director Rosana Kapeller-Libermann received the lowest support among nominees: 32,336,273 FOR vs 10,723,565 AGAINST (24.9% against).
• · The equity plan amendment had 10,825,547 shares AGAINST (20.7% of votes cast), indicating notable shareholder dissent.
• · Broker non-votes totaled 9,593,955 shares on director elections and advisory proposals.

23-06-2026

ConocoPhillips announced that Kelly B. Rose will retire as Senior Vice President, Legal, General Counsel and Corporate Secretary, effective September 1, 2026. Her replacement has not yet been named.

• · Retirement effective September 1, 2026.
• · Replacement to be announced later.

23-06-2026

Jewett-Cameron Trading Company Ltd. announced the retirement of Independent Director Ian Wendler from its Board of Directors, effective July 31, 2026. Mr. Wendler's departure is not due to any disagreement with the company, and a search to fill the resulting vacancy has been initiated. The filing contains no financial data or performance metrics.

• · Mr. Wendler was originally appointed to the Board in December 2023 and was reelected at the Shareholder's Meeting on February 27, 2026.
• · Mr. Wendler currently serves as a member of the Audit Committee.
• · The company is initiating a search to fill the vacancy left by Mr. Wendler's departure.

23-06-2026

Talphera, Inc. held its 2026 Annual Meeting on June 22, 2026, where stockholders elected three Class III directors (Marina Bozilenko, Joseph Todisco, Mark Wan) and ratified BPM LLP as independent auditor for fiscal 2026. Stockholders also approved, on an advisory basis, executive compensation, and approved amendments to the 2020 Equity Incentive Plan and the 2011 Employee Stock Purchase Plan. All proposals passed with strong support, though broker non-votes were significant on director elections and compensation-related items.

• · Broker non-votes totaled 7,732,743 on director elections and compensation-related proposals, representing about 24.6% of shares voted.
• · Proposal 2 (ratification of auditor) passed with 31,019,362 votes for, 356,608 against, and 60,967 abstentions, with no broker non-votes.
• · Proposal 3 (advisory vote on executive compensation) received 22,874,586 for, 786,249 against, and 43,359 abstentions.
• · Proposal 4 (2020 EIP amendment) received 22,602,504 for, 1,068,623 against, and 33,067 abstentions.
• · Proposal 5 (2011 ESPP amendment) received 23,020,334 for, 657,322 against, and 26,538 abstentions.
• · The filing date is June 23, 2026, and the meeting date was June 22, 2026.

23-06-2026

NIKE, Inc. announced that David M. Denton will join as Executive Vice President and CFO effective August 17, 2026, succeeding Matthew Friend, who will step down and support the transition through September 4. The company also provided an update on expected Q4 fiscal 2026 results, which will include a one-time benefit from tariff refunds not previously contemplated in guidance, while results excluding that benefit are expected to be generally in line with prior guidance.

• · Denton joins from Pfizer, where he served as CFO and EVP since May 2022.
• · Denton previously served as CFO and EVP of Lowe's Companies from 2018 to 2022.
• · Denton spent two decades at CVS Health, including as EVP and CFO.
• · Denton previously served on the boards of Haleon (2023–2024) and Tapestry (2014–2023), and is expected to serve on the board of Honeywell Aerospace after its spin-off.
• · Matthew Friend will participate in the Q4 fiscal 2026 earnings call on June 30 as planned.
• · The Q4 fiscal 2026 results will be reported on June 30, 2026.

23-06-2026

On June 16, 2026, the Board of Directors of Neuronetics, Inc. promoted Cory Anderson from Senior Vice President, Chief Technology Officer to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026. The promotion includes an increase in annual base salary to $425,000 and a target discretionary annual cash bonus of 45% of base salary. The filing does not disclose any negative or declining metrics.

• · The promotion is effective July 1, 2026.
• · Mr. Anderson, age 49, has over 25 years of experience in medical device companies.
• · He previously served as SVP R&D and Clinical, CTO since January 2025; SVP R&D and Clinical from January 2023 to December 2024; VP R&D and Clinical from January 2022 to December 2022; and VP Clinical Affairs and Medical Operations, Interim VP R&D from March 2021 to December 2021.
• · He holds Bachelor's and Master's degrees in Biomedical Engineering from Tulane University and an MBA from Emory University.
• · He is an inventor on seven issued U.S. patents and author of two peer-reviewed papers and one book chapter.
• · Mr. Anderson had previously entered into the Company's executive indemnification agreement, executive restrictive covenant and severance agreement, and restrictive covenant and invention assignment agreement.
• · There are no family relationships or related party transactions requiring disclosure under Item 404(a) of Regulation S-K.

23-06-2026

Emanuel "Manny" Chirico informed Conagra Brands on June 22, 2026 that he will not stand for reelection to the Board of Directors at the 2026 Annual Meeting in September, though he will serve through the remainder of his current term. The departure is not due to any disagreement with the Board or the Company.

• · Emanuel Chirico will continue to serve through the remainder of his current term.
• · The 2026 Annual Meeting of Shareholders is scheduled for September 2026.
• · The decision was not due to any disagreement with the Board or the Company.

23-06-2026

RPC, Inc. announced that President and CEO Ben M. Palmer plans to retire by the end of 2026 after a 30-year career with the company. The Board has initiated a search for his successor, expected to conclude before year-end 2026, with Palmer remaining in an advisory role post-retirement to ensure a smooth transition. The announcement highlights Palmer's leadership in strengthening the balance sheet, diversifying into higher-margin services, and expanding in the Permian Basin, but no specific financial metrics or performance data were provided in the filing.

• · Ben Palmer has served as President and CEO since 2022, and as CFO and Treasurer since 1996.
• · Palmer will continue in his role until a successor is named or December 31, 2026, whichever is earlier.
• · The Board intends to engage a leading independent search firm to assist in identifying the next CEO.
• · The search will focus on candidates with operational excellence in oilfield services and a growth focus while maintaining financial strength.

23-06-2026

Loop Industries appointed Jeffrey R. Geygan as an independent director on June 22, 2026, increasing the board size by one seat. Mr. Geygan brings extensive executive and board experience, including serving as Interim CEO of Rocky Mountain Chocolate Factory. He received a prorated grant of 5,170 restricted stock units under the company's equity plan.

• · Mr. Geygan was appointed on June 19, 2026, effective June 22, 2026.
• · He qualifies as an independent director under Nasdaq listing standards.
• · He serves as Interim CEO of Rocky Mountain Chocolate Factory since May 2024.
• · He was Chairman of Climb Global Solutions from May 2018 to February 2025.
• · He founded GVIC in August 2007 and served as CEO until May 2024.
• · The restricted stock units vest on the earlier of one year or the day before the next annual meeting.
• · No material transactions between the company and Mr. Geygan in the last fiscal year.

23-06-2026

BJ's Restaurants, Inc. (BJRI) disclosed in an 8-K filing that its Board of Directors approved amended compensation for non-employee directors, effective June 17, 2026. The changes include increases to annual cash retainers and restricted stock unit awards, with the base cash retainer rising by $5,000 to $80,000 and the annual RSU award increasing by $15,000 to $140,000. The adjustments reflect modest incremental increases across committee retainers and chair roles, with no declines or flat metrics noted.

• · The compensation changes were approved upon recommendation of the Compensation Committee and its compensation consultant.
• · The annual RSU award vests one year from the date of grant, with share count determined by the average closing price over 20 trading days ending on the grant date.
• · Finance Committee compensation will be paid in arrears to the date the committee was first established.
• · New non-employee directors receive a prorated initial equity award effective the beginning of the quarter they join the Board.
• · The filing was signed on June 23, 2026, by Lyle D. Tick, CEO and President.

23-06-2026

Cal-Maine Foods announced the appointment of Haley R. Fisackerly and Michael J. Highfield as independent directors, effective June 23, 2026, expanding the board from eight to ten directors. The appointments strengthen the board's expertise in operations, finance, and governance as the company pursues long-term strategic objectives. No negative or flat financial metrics were reported in this filing.

• · Mr. Fisackerly has over three decades of leadership experience in utility operations, regulatory affairs, and economic development, serving as President and CEO of Entergy Mississippi since 2008.
• · Dr. Highfield brings over two decades of experience in finance, banking, capital markets, and governance, and was recently named the next President and Chief Academic Officer of the Graduate School of Banking at LSU.
• · Both new directors will join the Board's Compensation, Audit, and Nominating and Corporate Governance Committees.
• · The company ceased to be a 'controlled company' under Nasdaq rules on April 14, 2025.
• · Cal-Maine completed the acquisition of Echo Lake Foods on June 2, 2025.
• · The company's flocks were impacted by HPAI in the third and fourth quarters of fiscal 2024 and again in March 2026.

23-06-2026

Tango Therapeutics appointed Robert Azelby to its Board of Directors, effective June 22, 2026. Mr. Azelby brings over 30 years of biopharmaceutical leadership, including oncology commercialization and corporate governance experience, as the company advances its lead candidate vopimetostat toward late-stage development for MTAP-deleted cancers. The appointment strengthens the board as Tango transitions from a research-led organization to a commercial-stage company.

• · Azelby served as President and CEO of Eliem Therapeutics (Oct 2020 – Feb 2023) and CEO of Alder BioPharmaceuticals (June 2018 – 2019 acquisition by Lundbeck).
• · He was EVP and Chief Commercial Officer of Juno Therapeutics from Nov 2015 through its acquisition by Celgene in 2018.
• · He spent 15 years at Amgen, concluding as VP and GM of Oncology, overseeing a $6B oncology portfolio.
• · Current board seats: ADC Therapeutics, Autolus Therapeutics, Cardinal Health.
• · MTAP deletion occurs in 10–15% of all human cancers, ~40% of pancreatic cancer, and ~15% of lung cancer.
• · Vopimetostat is an oral, once-daily, MTA-cooperative PRMT5 inhibitor being evaluated as monotherapy and in combination.

23-06-2026

Okta, Inc. held its 2026 annual meeting on June 18, 2026, where stockholders approved an amendment to the 2017 Equity Incentive Plan, removing the termination date, the evergreen provision, and liberal share recycling. Stockholders also elected two Class III directors, ratified Ernst & Young as independent auditor, and approved executive compensation on an advisory basis. The filing reflects governance updates but includes no financial performance data.

• · Stockholders elected Anthony Bates with 189,401,386 votes for and 14,712,063 withheld; David Schellhase with 197,790,448 for and 6,323,001 withheld.
• · Ratification of Ernst & Young as independent auditor passed with 222,282,460 for, 1,836,402 against, and 315,470 abstain.
• · Advisory vote on executive compensation passed with 154,747,380 for, 49,257,140 against, and 108,929 abstain.
• · Amendment to 2017 Equity Incentive Plan approved with 144,073,135 for, 59,915,901 against, and 124,413 abstain.
• · Broker non-votes were 20,320,883 on director elections, advisory compensation, and equity plan proposals.

23-06-2026

Theravance Biopharma, Inc. filed an 8-K on June 23, 2026, reporting a director or officer departure or election under Item 5.02. The filing was signed by CEO Rick E. Winningham, but no specific details on the officer change or financial results were disclosed in the provided content.

• · The filing is an 8-K under Item 5.02, which typically covers changes in directors or principal officers.
• · The filing date is June 23, 2026, and covers the period ending June 30, 2026.
• · No financial data, performance metrics, or specific officer change details were included in the provided text.

23-06-2026

Laser Photonics Corp (LASE) announced that President and CEO Wayne Tupuola will take a three-month leave of absence for health reasons, effective June 16, 2026. The Board appointed Executive Vice President of Global Operations and Strategy, Ann Tewari, as Interim President to lead the company during this period. The filing does not disclose any financial impact or performance metrics.

• · The leave of absence is for three months, starting June 16, 2026.
• · Ann Tewari was previously Executive Vice President of Global Operations and Strategy before being appointed Interim President.
• · The filing was signed by Ann Tewari as Interim President on June 23, 2026.

23-06-2026

FibroBiologics held its 2026 Annual Meeting on June 22, 2026, where stockholders approved the new 2026 Equity and Incentive Compensation Plan, replacing the 2022 plan, and elected Pete O'Heeron as a Class III director. The 2026 Plan makes 2,061,968 shares available for equity awards, including 2,000,000 new shares and 61,968 carryover shares, with an evergreen provision allowing annual increases of up to 4% of outstanding shares through 2036. However, the vote for the 2026 Plan showed notable opposition, with 297,025 votes against and 25,317 abstentions, representing approximately 11.3% of votes cast (excluding broker non-votes).

• · The 2026 Plan includes an evergreen provision allowing annual share increases from 2027 to 2036, up to 4% of outstanding shares or a lower amount determined by the Board.
• · Incentive stock options under the 2026 Plan are capped at 2,000,000 shares.
• · Non-employee Board members are limited to $800,000 in compensation per calendar year under the 2026 Plan.
• · Stacy Coen did not stand for re-election, and her term as Class III director expired at the conclusion of the Annual Meeting.
• · The auditor ratification (Proposal 2) passed with 4,112,372 votes for, 43,143 against, and 19,276 abstentions, with no broker non-votes.
• · The warrant issuance approval (Proposal 3) received 2,820,710 votes for, 97,016 against, and 24,774 abstentions, with 1,232,291 broker non-votes.
• · The 2026 Plan approval (Proposal 4) received 2,620,158 votes for, 297,025 against, and 25,317 abstentions, with 1,232,291 broker non-votes.

23-06-2026

Provident Bank appointed Adriano Duarte as EVP and Chief Financial Officer of both the bank and its parent company, Provident Financial Services Inc. (NYSE: PFS), effective July 1, 2026. Duarte, who joined through the SB One Bank acquisition in 2020 and most recently served as EVP and Chief Accounting Officer, succeeds Thomas Lyons after his retirement. The bank reported total assets of $25.20 billion as of March 31, 2026, but no financial performance metrics or period-over-period comparisons were provided in this filing.

• · Adriano Duarte has more than 30 years of banking and financial services experience.
• · He holds a Bachelor of Science in Accounting and an MBA with a concentration in Finance from Rutgers University and is a Certified Public Accountant.
• · Duarte previously served as Chief Financial Officer of SB One Bank and held senior finance roles at Investors Bank.
• · Provident Bank was founded in 1839 and is the oldest community-focused financial institution based in New Jersey.
• · The bank offers fiduciary and wealth management services through Beacon Trust Company and insurance services through Provident Protection Plus, Inc.

23-06-2026

On June 17, 2026, the Compensation Committee of Blockchain Digital Infrastructure, Inc. approved one-time special discretionary cash bonus awards totaling $350,000 to two executive officers: CEO Jerry Tang ($250,000) and CFO Jolienne Halisky ($100,000). The bonuses recognize contributions from January 2025 through the approval date, including the company's NYSE American listing, strategic repositioning toward AI and high-performance computing infrastructure, and data center pipeline development. The company is still developing its executive compensation program for a publicly traded company and expects to provide further details in future filings.

• · The company is an emerging growth company as defined under SEC rules.
• · The company's common stock trades on NYSE American under the symbol AIB.
• · The company was formed via a business combination with Signing Day Sports, Inc., as previously disclosed in a Form S-4 registration statement.
• · A proxy statement related to the business combination was filed with the SEC on April 29, 2026.
• · The company expects to provide additional details on its executive compensation program in future SEC filings.

23-06-2026

The Wendy's Company announced the appointment of Steve Cirulis as Chief Financial Officer and Chief Strategy Officer, effective June 23, 2026, succeeding Ken Cook. Cook will remain in an advisory role through July to ensure a smooth transition. Cirulis previously served as CFO and Chief Strategy Officer at Potbelly Sandwich Works, where he partnered with current Wendy's CEO Bob Wright to lead a turnaround that resulted in a more than 500% increase in share price and double-digit growth in average unit volumes.

• · Ken Cook served as CFO since 2024 and also served as Interim CEO during his tenure.
• · Cirulis has nearly 30 years of experience with leading brands and consultancies in food, beverage, retail, and restaurant spaces.
• · Wendy's operates more than 7,000 restaurants worldwide.

23-06-2026

Daniel M. Skovronsky, M.D., Ph.D., resigned from the Board of Directors of Myriad Genetics, Inc., effective June 17, 2026. The resignation was not due to any disagreement with the company or its operations, policies, or practices.

• · The resignation was effective immediately on June 17, 2026.
• · The Form 8-K was filed on June 23, 2026.
• · The resignation was not related to any disagreement with the company.

23-06-2026

Calidi Biotherapeutics appointed Corsee Sanders, Ph.D., a former Genentech/Roche and Celgene executive, to its Board of Directors as an independent director effective June 17, 2026. Dr. Sanders brings over three decades of biopharmaceutical development and clinical operations experience to help guide the advancement of Calidi's CLD-401 and RedTail platform into the clinic. The filing does not disclose any financial terms or changes to the company's financial position.

• · Dr. Sanders currently serves on the boards of Legend Biotech (NASDAQ: LEGN), Ultragenyx (NASDAQ: RARE), and AltruBio Inc.
• · She is on the Board of Advisors of the Fred Hutchinson Cancer Center and recently transitioned off the board of BeOne Ltd. (NASDAQ: ONC).
• · Dr. Sanders holds a Ph.D. in statistics from the Wharton Doctoral Program at the University of Pennsylvania.
• · CLD-401 is currently in IND-enabling studies targeting non-small cell lung cancer, head and neck cancer, and other tumor types.

23-06-2026

Clean Energy Fuels Corp. appointed Bart Frabotta as COO, effective June 23, 2026. Frabotta, who joined the company in 2010 and served as Group VP of Operations since 2021, will oversee operations, RNG/LNG production, engineering, supply chain, IT, and AI initiatives. The filing does not include any financial figures, period-over-period data, or performance metrics.

• · Frabotta has over 20 years of leadership experience in energy infrastructure, construction, operations, technology, and industrial services.
• · He will oversee stations, RNG and LNG production, engineering and construction, field services, supply chain, EHS, IT, and AI.
• · CEO Clay Corbus cited Frabotta's leadership in driving improvements in reliability, efficiency, and cost structure across the station network.
• · The appointment makes Frabotta a named executive officer.

23-06-2026

Illumina, Inc. announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky, Chief Scientific and Product Officer of Eli Lilly and Company, brings extensive pharmaceutical R&D and scientific leadership experience to Illumina's board. The appointment is expected to strengthen Illumina's innovation in genomics, multiomics, and precision medicine.

• · Dr. Skovronsky joined Lilly in 2010 following the acquisition of Avid Radiopharmaceuticals, a company he founded in 2004 and led as CEO.
• · He previously served on the Board of Directors of Myriad Genetics, Inc.
• · He holds a BS in molecular biophysics and biochemistry from Yale University, and both an MD and PhD from the University of Pennsylvania.
• · He completed residency in pathology and fellowship in neuropathology at the Hospital of the University of Pennsylvania.

23-06-2026

LCI Industries disclosed amended and restated employment agreements for two key executives, Ryan R. Smith (Group President, North America) and Jamie M. Schnur (President, Aftermarket & Technology Groups), effective June 19, 2026. The agreements introduce an 'Approved Retirement' provision that allows executives to receive severance benefits upon retirement or death after one year. Notably, Mr. Smith's severance multiple was reduced from three times to two times base salary and average bonus, with the severance payment and restrictive covenant periods shortened from 36 to 24 months.

• · The A&R Employment Agreements were entered into on June 19, 2026, and are effective as of that date.
• · Approved Retirement eligibility begins on the first anniversary of the effective date, extendable to up to 18 months in certain corporate transaction scenarios.
• · The agreements apply the definition of 'Good Reason' to stock-based incentive awards held by the executives.
• · Copies of the A&R Employment Agreements are expected to be filed as exhibits to the Company's next Quarterly Report on Form 10-Q.

23-06-2026

Bank First Corporation elected three new directors to its Board of Directors on June 16, 2026: SriRaj Kantamneni, Tracy C. Pearson, and William J. Ring, each serving a three-year term. These individuals were also elected to the board of the company's wholly owned banking subsidiary, Bank First, N.A. No financial metrics or period-over-period comparisons were provided in this filing.

• · The new directors were elected for a three-year term.
• · The elections occurred on June 16, 2026, and the filing was made on June 23, 2026.
• · The directors also joined the board of Bank First, N.A., the wholly owned banking subsidiary.

23-06-2026

Alpha Cognition Inc. (ACOG) held its 2026 annual meeting on June 16, 2026, where Dr. Robert Wills was appointed as non-executive Chair of the Board, filling the vacancy left by Len Mertz. All six director nominees were elected, and CBIZ CPAs P.C. was ratified as the independent auditor. The meeting had a quorum with 10,535,277 shares represented, but notable broker non-votes of 4,099,438 were recorded for each director nominee, indicating significant institutional abstention.

• · Dr. Robert Wills was elected with 6,412,233 votes for and 23,606 votes withheld.
• · Rajeev 'Rob' Bakshi received the lowest votes among nominees: 4,436,011 for and 1,999,828 withheld.
• · Bethany Sensenig had 6,164,918 votes for and 270,921 withheld.
• · Proposal to ratify auditor received 10,000,365 votes for, 533,188 against, and 1,723 abstentions.
• · Meeting was held at Timarron Country Club, Southlake, Texas.

23-06-2026

All In FutureTech Alliance Inc. (Nasdaq: AIFA) announced the resignation of James Li as CEO and Chairman for personal reasons, with Li remaining as President and Director during a transition period. The Board elected Li Shanglong (Michael Li), a prominent AI investor and bestselling author with over 16 million followers, as the new Chairman, and appointed Shao Weizhi (Eric Shao) as the new CEO. The changes aim to strengthen the company's AI-focused dual-engine strategy (AI infrastructure network and AI application services matrix) and capital markets positioning, though the company faces execution risks and ongoing Nasdaq listing challenges.

• · James Li will remain as President and Director during a transition period to ensure continuity.
• · Li Shanglong is Founding Partner of Aivolution Venture, based in Silicon Valley.
• · Li Shanglong's fund management scale increased 600% from 2025 to 2026.
• · Eric Shao's previous company Beauty Diary achieved RMB 2.0B GMV in 2021 and managed over 500 influencer accounts.
• · Eric Shao holds a B.S. from NYU, an M.S. from Columbia, and completed doctoral studies at Columbia.
• · The company plans to launch a new round of financing led by the new CEO.
• · The company's strategic priorities include silicon photonics compute, cross-border fiber, submarine cables, AI education, AI entertainment, and strategic M&A.
• · The company's name changed from Allied Gaming & Entertainment Inc. to All In FutureTech Alliance Inc.

23-06-2026

MGE Energy, Inc. announced the planned retirement of James J. Lorenz, Vice President – Energy Operations of Madison Gas and Electric Company, effective December 31, 2026. John T. Robson, currently Assistant Vice President – Energy Engineering and Production, will succeed him as Vice President – Energy Operations effective January 1, 2027. The transition is orderly with Mr. Lorenz continuing in his role until retirement.

• · James J. Lorenz notified the company of his retirement on June 19, 2026.
• · Mr. Lorenz will continue to serve in his current role until his retirement date of December 31, 2026.
• · John T. Robson will be appointed Vice President – Energy Operations effective January 1, 2027.
• · The filing was made on June 23, 2026.

23-06-2026

Vaxcyte, Inc. announced the retirement of board member Jacks Lee effective June 17, 2026, and the appointment of Dr. Moncef Slaoui as a Class II independent director. Mr. Lee will continue as a consultant on global strategic supply and manufacturing operations. Dr. Slaoui's annual equity grant is set at $430,000.

• · Mr. Lee's retirement was not due to any disagreement with the company.
• · Dr. Slaoui qualifies as an independent director under Nasdaq Rule 5605(a)(2).
• · Dr. Slaoui's term expires at the 2028 annual meeting of stockholders.
• · The company entered into its standard form of indemnification agreement with Dr. Slaoui.